These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28653802)

  • 1. Safety profile of H1-antihistamines in pediatrics: an analysis based on data from VigiBase.
    Motola D; Donati M; Biagi C; Calamelli E; Cipriani F; Melis M; Monaco L; Vaccheri A; Ricci G
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1164-1171. PubMed ID: 28653802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of H1-antihistamines with torsade de pointes: a pharmacovigilance study of the food and drug administration adverse event reporting system.
    Ali Z; Ismail M; Khan F; Sajid H
    Expert Opin Drug Saf; 2021 Jan; 20(1):101-107. PubMed ID: 33141610
    [No Abstract]   [Full Text] [Related]  

  • 3. Central nervous system effects of H1-receptor antagonists in the elderly.
    Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe.
    Poluzzi E; Raschi E; Godman B; Koci A; Moretti U; Kalaba M; Wettermark B; Sturkenboom M; De Ponti F
    PLoS One; 2015; 10(3):e0119551. PubMed ID: 25785934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.
    de Bie S; Verhamme KM; Straus SM; Stricker BH; Sturkenboom MC
    Drug Saf; 2012 Apr; 35(4):335-46. PubMed ID: 22435344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice.
    Mann RD; Pearce GL; Dunn N; Shakir S
    BMJ; 2000 Apr; 320(7243):1184-6. PubMed ID: 10784544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
    Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
    Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
    Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
    Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
    Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Knowledge creation about adverse drug reactions in the paediatric population].
    Aagaard L
    Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
    Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
    Star K; Norén GN; Nordin K; Edwards IR
    Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of non-sedating antihistamines.
    Lindquist M; Edwards IR
    Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study.
    Lombardi N; Crescioli G; Bettiol A; Marconi E; Vitiello A; Bonaiuti R; Calvani AM; Masi S; Lucenteforte E; Mugelli A; Giovannelli L; Vannacci A
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):16. PubMed ID: 29661234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase.
    Montastruc F; Palmaro A; Bagheri H; Schmitt L; Montastruc JL; Lapeyre-Mestre M
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1556-65. PubMed ID: 26256010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.